Breast for abnormalities. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Breast Cell Line, Tumor Tumor Cells, Cultured Milk, Human Nipples Mammary Glands, Human MCF-7 Cells Axilla Brain Lymph Nodes Epithelial Cells Chromosomes, Human, Pair 17 Mammary Glands, Animal Chromosomes, Human, Pair 11 Cell Line Neoplastic Stem Cells Chromosomes, Human, Pair 13

Organisms3

Mice, Nude Mice, Transgenic Mice, Knockout

Diseases54

Carcinoma, Ductal, Breast Breast Diseases Breast Neoplasms, Male Fibrocystic Breast Disease Abnormalities, Multiple Carcinoma, Intraductal, Noninfiltrating Carcinoma, Lobular Chromosome Aberrations Neoplasm Invasiveness Neoplasm Metastasis Lymphatic Metastasis Breast Cyst Carcinoma Fibroadenoma Mammary Neoplasms, Experimental Congenital Abnormalities Chromosome Disorders Genetic Predisposition to Disease Eye Abnormalities Neoplasms, Hormone-Dependent Carcinoma in Situ Carcinoma, Ductal Triple Negative Breast Neoplasms Inflammatory Breast Neoplasms Neoplasm Recurrence, Local Disease Progression Ovarian Neoplasms Neoplasms Cardiovascular Abnormalities Craniofacial Abnormalities Syndrome Bone Neoplasms Disease Models, Animal Aneuploidy Adenofibroma Skin Abnormalities Cell Transformation, Neoplastic Neoplasms, Second Primary Trisomy Urogenital Abnormalities Musculoskeletal Abnormalities Adenocarcinoma Hyperplasia Gynecomastia Tooth Abnormalities Translocation, Genetic Lung Neoplasms Neoplasms, Basal Cell Lymphedema Chromosome Deletion Neoplasms, Multiple Primary Sex Chromosome Aberrations Abnormalities, Drug-Induced Neovascularization, Pathologic

Chemicals and Drugs42

Receptors, Estrogen Receptor, erbB-2 Receptors, Progesterone Tamoxifen Tumor Markers, Biological Antineoplastic Agents, Hormonal Neoplasm Proteins Antineoplastic Agents Estrogens Estrogen Receptor alpha BRCA2 Protein BRCA1 Protein RNA, Messenger Aromatase Inhibitors Estrogen Antagonists DNA, Neoplasm Estradiol Cyclophosphamide Selective Estrogen Receptor Modulators Epirubicin Ki-67 Antigen Transcription Factors Antibodies, Monoclonal Antibodies, Monoclonal, Humanized RNA, Neoplasm Nitriles Tumor Suppressor Protein p53 Tumor Suppressor Proteins Taxoids RNA, Small Interfering Mucin-1 Fluorouracil DNA-Binding Proteins Antigens, CD24 Triazoles Receptor, Epidermal Growth Factor Antigens, Neoplasm Antineoplastic Agents, Phytogenic Aromatase Nuclear Proteins DNA Primers Radiopharmaceuticals

Analytical, Diagnostic and Therapeutic Techniques and Equipment83

Mammography Breast Implants Breast Self-Examination Prognosis Case-Control Studies Mastectomy Risk Factors Ultrasonography, Mammary Immunohistochemistry Neoplasm Staging Mammaplasty Mastectomy, Segmental Magnetic Resonance Imaging Follow-Up Studies Retrospective Studies Prospective Studies Chemotherapy, Adjuvant Sensitivity and Specificity Mammary Neoplasms, Experimental Karyotyping Treatment Outcome Cohort Studies Breast Implantation In Situ Hybridization, Fluorescence Incidence Gene Expression Profiling Survival Analysis Mass Screening Disease-Free Survival Reverse Transcriptase Polymerase Chain Reaction Risk Antineoplastic Combined Chemotherapy Protocols Predictive Value of Tests Risk Assessment Reproducibility of Results Biopsy, Needle Biopsy Survival Rate Multivariate Analysis Blotting, Western Odds Ratio Polymerase Chain Reaction Mastectomy, Modified Radical Oligonucleotide Array Sequence Analysis Proportional Hazards Models Neoadjuvant Therapy Pedigree Disease Models, Animal Genetic Testing Logistic Models Immunoenzyme Techniques DNA Mutational Analysis Transplantation, Heterologous Tissue Array Analysis Tomography, X-Ray Computed Radiotherapy, Adjuvant Neoplasm Transplantation Reference Values Questionnaires Analysis of Variance Transfection Kaplan-Meier Estimate Xenograft Model Antitumor Assays Registries Sentinel Lymph Node Biopsy Mastectomy, Radical Neoplasm Grading Tumor Burden SEER Program Estrogen Replacement Therapy Confidence Intervals False Negative Reactions Radiographic Image Enhancement Electrocardiography Chi-Square Distribution Lymph Node Excision Cytogenetic Analysis Pilot Projects Clinical Trials as Topic Prevalence False Positive Reactions Drug Administration Schedule Models, Biological

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes59

Breast Feeding Gene Expression Regulation, Neoplastic Chromosome Aberrations Genes, BRCA1 Postmenopause Time Factors Mutation Premenopause Sensitivity and Specificity Cell Proliferation Genetic Predisposition to Disease Menopause Phenotype Genes, BRCA2 Pregnancy Genes, erbB-2 Signal Transduction Risk Drug Resistance, Neoplasm Apoptosis Odds Ratio Heterozygote Cell Division Genotype Gene Amplification Base Sequence Germ-Line Mutation Aneuploidy Cell Movement Gene Expression Trisomy Parity Down-Regulation Promoter Regions, Genetic Chromosomes, Human, Pair 17 Polymorphism, Single Nucleotide Transfection Polymorphism, Genetic Dose-Response Relationship, Drug Alleles DNA Methylation Translocation, Genetic Cell Cycle Up-Regulation Chromosome Deletion Loss of Heterozygosity Genes, Tumor Suppressor Cell Growth Processes Chromosomes, Human, Pair 11 Genes, p53 Phosphorylation Gene Silencing RNA Interference Chi-Square Distribution Gene Deletion Homozygote Chromosomes, Human, Pair 13 Sex Chromosome Aberrations Algorithms

Disciplines and Occupations2

Immunohistochemistry Genetic Counseling

Technology, Industry, Agriculture1

Information Science11

Incidence Survival Rate Base Sequence Molecular Sequence Data Image Processing, Computer-Assisted Questionnaires Registries SEER Program Radiographic Image Enhancement Prevalence Algorithms

Named Groups3

Infant, Newborn Survivors European Continental Ancestry Group

Health Care37

Case-Control Studies Risk Factors Follow-Up Studies Retrospective Studies Prospective Studies Sensitivity and Specificity Treatment Outcome Cohort Studies Age Factors Incidence Survival Analysis Mass Screening Disease-Free Survival Risk Predictive Value of Tests Risk Assessment Reproducibility of Results Survival Rate Multivariate Analysis Odds Ratio Proportional Hazards Models Genetic Testing Logistic Models Parity Questionnaires Analysis of Variance Kaplan-Meier Estimate Registries Age of Onset SEER Program Confidence Intervals Genetic Counseling Chi-Square Distribution Pilot Projects Clinical Trials as Topic Prevalence Family Health

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Breast Carcinoma, Ductal, Breast Breast Diseases Breast Feeding Breast Neoplasms, Male Receptors, Estrogen Mammography Fibrocystic Breast Disease Cell Line, Tumor Breast Implants Receptor, erbB-2 Breast Self-Examination Receptors, Progesterone Tamoxifen Prognosis Gene Expression Regulation, Neoplastic Abnormalities, Multiple Case-Control Studies Carcinoma, Intraductal, Noninfiltrating Mastectomy Tumor Markers, Biological Risk Factors Carcinoma, Lobular Chromosome Aberrations Neoplasm Invasiveness Ultrasonography, Mammary Immunohistochemistry Neoplasm Metastasis Genes, BRCA1 Antineoplastic Agents, Hormonal Neoplasm Staging Lymphatic Metastasis Postmenopause Tumor Cells, Cultured Time Factors Neoplasm Proteins Milk, Human Mammaplasty Breast Cyst Mastectomy, Segmental Antineoplastic Agents Carcinoma Magnetic Resonance Imaging Follow-Up Studies Retrospective Studies Nipples Mutation Prospective Studies Estrogens Chemotherapy, Adjuvant Mammary Glands, Human Estrogen Receptor alpha MCF-7 Cells Premenopause Fibroadenoma Sensitivity and Specificity Mammary Neoplasms, Experimental Congenital Abnormalities Karyotyping Cell Proliferation Chromosome Disorders Treatment Outcome Cohort Studies BRCA2 Protein Genetic Predisposition to Disease BRCA1 Protein Breast Implantation Menopause Phenotype Age Factors RNA, Messenger In Situ Hybridization, Fluorescence Axilla Eye Abnormalities Genes, BRCA2 Incidence Gene Expression Profiling Survival Analysis Mass Screening Pregnancy Neoplasms, Hormone-Dependent Carcinoma in Situ Genes, erbB-2 Disease-Free Survival Carcinoma, Ductal Reverse Transcriptase Polymerase Chain Reaction Triple Negative Breast Neoplasms Inflammatory Breast Neoplasms Neoplasm Recurrence, Local Signal Transduction Aromatase Inhibitors Risk Antineoplastic Combined Chemotherapy Protocols Predictive Value of Tests Estrogen Antagonists Disease Progression Risk Assessment Mice, Nude Reproducibility of Results Biopsy, Needle

No FAQ available that match "breast for abnormalities"